{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T04:28:15Z","timestamp":1740112095009,"version":"3.37.3"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["Nr 257144"],"award-info":[{"award-number":["Nr 257144"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","thegreenjournal.com","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.radonc.2024.110612","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T03:51:08Z","timestamp":1731124268000},"page":"110612","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Protocol compliance in a multicentric phase III trial investigating scheduled adaptive radiotherapy and dose painting in head and neck cancer"],"prefix":"10.1016","volume":"202","author":[{"given":"Anna Liza M.P.","family":"de Leeuw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordi","family":"Giralt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yungan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2700-3522","authenticated-orcid":false,"given":"Sergi","family":"Benavente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thanh-V\u00e2n F","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4317-9181","authenticated-orcid":false,"given":"Frank J.P.","family":"Hoebers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann","family":"Hoeben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6062-5457","authenticated-orcid":false,"given":"Chris H.J.","family":"Terhaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lip Wai","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8118-1066","authenticated-orcid":false,"given":"Signe","family":"Friesland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roel J.H.M.","family":"Steenbakkers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Tans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon R.","family":"van Kranen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen B.","family":"van de Kamer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6601-3419","authenticated-orcid":false,"given":"Harry","family":"Bartelink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coen R.N.","family":"Rasch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan-Jakob","family":"Sonke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5928-4704","authenticated-orcid":false,"given":"Olga","family":"Hamming-Vrieze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2024.110612_b0005","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2012.08.008","article-title":"QA makes a clinical trial stronger: Evidence-based medicine in radiation therapy","volume":"105","author":"Weber","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110612_b0010","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/acm2.12384","article-title":"Executive summary of AAPM Report Task Group 113: Guidance for the physics aspects of clinical trials","volume":"19","author":"Moran","year":"2018","journal-title":"J Appl Clin Med Phys"},{"key":"10.1016\/j.radonc.2024.110612_b0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.radonc.2021.11.018","article-title":"The radiotherapy quality assurance gap among phase III cancer clinical trials","volume":"166","author":"Corrigan","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110612_b0020","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1200\/JCO.2009.27.4498","article-title":"Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: Results from TROG 02.02","volume":"28","author":"Peters","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110612_b0025","first-page":"1","article-title":"The impact of clinical trial quality assurance on outcome in head and neck radiotherapy treatment. Front","volume":"9","author":"Zhong","year":"2019","journal-title":"Oncol"},{"key":"10.1016\/j.radonc.2024.110612_b0030","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.ijrobp.2014.08.348","article-title":"Global harmonization of quality assurance naming conventions in radiation therapy clinical trials","volume":"90","author":"Melidis","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110612_b0035","article-title":"A multicentric randomized controlled phase III trial of adaptive and 18F-FDG-PET-guided dose-redistribution in locally advanced head and neck squamous cell carcinoma (ARTFORCE)","volume":"196","author":"De","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110612_b0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.radonc.2021.01.013","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH\u00ad NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group HHS Public Access","volume":"156","author":"Lacas","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110612_b0045","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.radonc.2020.12.025","article-title":"Prolongation of definitive head and neck cancer radiotherapy: Survival impact and predisposing factors","volume":"156","author":"Xiang","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110612_b0050","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1200\/JCO.2014.56.5218","article-title":"Institutional clinical trial accrual volume and survival of patients with head and neck cancer","volume":"33","author":"Wuthrick","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2024.110612_b0055","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/bjc.2013.458","article-title":"Critical weight loss is a major prognostic indicator for disease-specific survival in patients with head and neck cancer receiving radiotherapy","volume":"109","author":"Langius","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.radonc.2024.110612_b0060","first-page":"1391","article-title":"Adult height and head and neck cancer: A pooled analysis within the INHANCE Consortium","volume":"36","author":"Leoncini","year":"2014","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2024.110612_b0065","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ijrobp.2019.06.2545","article-title":"A dose of reality: how 20 years of incomplete physics and dosimetry reporting in radiobiology studies may have contributed to the reproducibility crisis","volume":"106","author":"Draeger","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110612_b0070","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.ijrobp.2018.07.2001","article-title":"A call to arms: radiation therapy quality assurance in the next generation of clinical trials","volume":"102","author":"McDowell","year":"2018","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110612_b0075","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.radonc.2014.04.015","article-title":"Outcome impact and cost-effectiveness of quality assurance for radiotherapy planned for the EORTC 22071\u201324071 prospective study for head and neck cancer","volume":"111","author":"Weber","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110612_b0080","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.meddos.2020.12.002","article-title":"Why all radiotherapy planning studies are wrong but some are useful","volume":"46","author":"Eaton","year":"2021","journal-title":"Med Dosim"},{"key":"10.1016\/j.radonc.2024.110612_b0085","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ijrobp.2020.04.030","article-title":"Single-center prospective trial investigating the feasibility of serial FDG-PET guided adaptive radiation therapy for head and neck cancer","volume":"108","author":"Gouw","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.radonc.2024.110612_b0090","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2019.04.012","article-title":"Impact of deviations in target volume delineation \u2013 Time for a new RTQA approach?","volume":"137","author":"Cox","year":"2019","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110612_b0095","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.radonc.2016.10.012","article-title":"Analysis of GTV reduction during radiotherapy for oropharyngeal cancer: Implications for adaptive radiotherapy","volume":"122","author":"Hamming-Vrieze","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110612_b0100","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.radonc.2017.02.005","article-title":"Modality-specific target definition for laryngeal and hypopharyngeal cancer on FDG-PET CT and MRI","volume":"123","author":"Ligtenberg","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110612_b0105","doi-asserted-by":"crossref","first-page":"S225","DOI":"10.1016\/S0167-8140(24)00538-3","article-title":"191 dose prescription variability in oropharynx cancer radiotherapy","volume":"192","author":"Hansen","year":"2024","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.radonc.2024.110612_b0110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4103\/jmp.JMP_111_19","article-title":"Dose calculation comparisons between three modern treatment planning systems","volume":"45","author":"Bosse","year":"2020","journal-title":"J Med Phys"},{"key":"10.1016\/j.radonc.2024.110612_b0115","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.radonc.2020.09.008","article-title":"Overview of artificial intelligence-based applications in radiotherapy: Recommendations for implementation and quality assurance","volume":"153","author":"Vandewinckele","year":"2020","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024042749?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167814024042749?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T05:30:18Z","timestamp":1734586218000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167814024042749"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":23,"alternative-id":["S0167814024042749"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110612","relation":{},"ISSN":["0167-8140"],"issn-type":[{"type":"print","value":"0167-8140"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protocol compliance in a multicentric phase III trial investigating scheduled adaptive radiotherapy and dose painting in head and neck cancer","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2024.110612","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110612"}}